BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17668426)

  • 41. VEGF as a therapeutic target in cancer.
    Ferrara N
    Oncology; 2005; 69 Suppl 3():11-6. PubMed ID: 16301831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
    Bikfalvi A
    J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted therapies in bladder cancer--an update.
    Black PC; Agarwal PK; Dinney CP
    Urol Oncol; 2007; 25(5):433-8. PubMed ID: 17826665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?].
    Jayet C; Deperthes D; Leisinger HJ
    Ann Urol (Paris); 2002 Jul; 36(4):258-63. PubMed ID: 12162191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
    Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
    Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia-regulated angiogenic inhibitors.
    Messmer-Blust A; An X; Li J
    Trends Cardiovasc Med; 2009 Nov; 19(8):252-6. PubMed ID: 20447566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenesis in cancer - general pathways and their therapeutic implications.
    Dimova I; Popivanov G; Djonov V
    J BUON; 2014; 19(1):15-21. PubMed ID: 24659637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.
    Streeter EH; Crew JP
    Anticancer Res; 2001; 21(6B):4355-63. PubMed ID: 11908691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiogenesis in urological malignancy.
    O'Brien TS; Harris AL
    Br J Urol; 1995 Dec; 76(6):675-82. PubMed ID: 8535707
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiangiogenesis therapeutic strategies in prostate cancer.
    Macpherson GR; Ng SS; Lakhani NJ; Price DK; Venitz J; Figg WD
    Cancer Metastasis Rev; 2002; 21(1):93-106. PubMed ID: 12400998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular targeting and the inhibition of angiogenesis.
    Bicknell R
    Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.
    Reynolds AR; Kyprianou N
    Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S144-52. PubMed ID: 16465179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Angiogenic Factors for the Treatment of Medulloblastoma.
    Saker Z; Rizk M; Bahmad HF; Nabha SM
    Curr Treat Options Oncol; 2022 Jun; 23(6):864-886. PubMed ID: 35412196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of angiogenesis as a therapeutic strategy against brain tumors.
    Puduvalli VK
    Cancer Treat Res; 2004; 117():307-36. PubMed ID: 15015567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.
    Cimadamore A; Scarpelli M; Piva F; Massari F; Gasparrini S; Doria A; Cheng L; Lopez-Beltran A; Montironi R
    Future Oncol; 2017 May; 13(12):1105-1114. PubMed ID: 28147707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in immuno-oncology and its application to urological cancers.
    Mataraza JM; Gotwals P
    BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer.
    Lyu J; Yang EJ; Shim JS
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Connecting a tumor to the environment.
    Entschladen F; Palm D; Drell TL; Lang K; Zaenker KS
    Curr Pharm Des; 2007; 13(33):3440-4. PubMed ID: 18045197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.